386 related articles for article (PubMed ID: 1503431)
1. Active efflux mechanisms for antimicrobial resistance.
Levy SB
Antimicrob Agents Chemother; 1992 Apr; 36(4):695-703. PubMed ID: 1503431
[No Abstract] [Full Text] [Related]
2. [Mechanisms of bacterial resistance to quinolones].
Taléns-Visconti R; Garrigues TM; Cantón E
Rev Esp Quimioter; 2002 Mar; 15(1):25-31. PubMed ID: 12582434
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance to quinolones and clinical perspectives.
Piddock LJ; Wise R
J Antimicrob Chemother; 1989 Apr; 23(4):475-80. PubMed ID: 2663809
[No Abstract] [Full Text] [Related]
4. Bacterial resistance to the quinolone antimicrobial agents.
Hooper DC; Wolfson JS
Am J Med; 1989 Dec; 87(6C):17S-23S. PubMed ID: 2690616
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of resistance to quinolones.
Cambau E; Gutmann L
Drugs; 1993; 45 Suppl 3():15-23. PubMed ID: 7689446
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of tetracycline-resistant strains of Ureaplasma urealyticum to newer macrolides and quinolones, and a streptogramin.
Renaudin H; Bébéar C; Robertson JA
Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):984-6. PubMed ID: 1794374
[No Abstract] [Full Text] [Related]
7. Lomefloxacin disc susceptibility criteria--a reappraisal.
Smith JM; Hashmi ZS
J Antimicrob Chemother; 1990 Jul; 26(1):152-3. PubMed ID: 2211438
[No Abstract] [Full Text] [Related]
8. Mechanisms of resistance to quinolones.
Hirai K; Mitsuhashi S
Prog Drug Res; 1992; 38():107-20. PubMed ID: 1609109
[No Abstract] [Full Text] [Related]
9. Prevention and control of resistance to the quinolones.
Vellend H
Clin Invest Med; 1989 Feb; 12(1):74-5. PubMed ID: 2920485
[No Abstract] [Full Text] [Related]
10. Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City.
Durazo F; Resano F; Gonzalez MA
Diagn Microbiol Infect Dis; 1990; 13(1):71-5. PubMed ID: 2331854
[TBL] [Abstract][Full Text] [Related]
11. Resistance to quinolones in gram-negative microorganisms: mechanisms and prevention.
Baquero F
Eur Urol; 1990; 17 Suppl 1():3-12. PubMed ID: 2162298
[TBL] [Abstract][Full Text] [Related]
12. Lomefloxacin sensitivities.
Smith JM; Hashmi ZS
N Z Med J; 1990 Jun; 103(891):277-8. PubMed ID: 2356052
[No Abstract] [Full Text] [Related]
13. [Quinolones: new synthetic antimicrobial agents].
Lopes HV
AMB Rev Assoc Med Bras; 1988; 34(2):54-60. PubMed ID: 3072599
[No Abstract] [Full Text] [Related]
14. Plasmid-mediated 4-quinolone resistance: a real or apparent absence?
Courvalin P
Antimicrob Agents Chemother; 1990 May; 34(5):681-4. PubMed ID: 2193615
[No Abstract] [Full Text] [Related]
15. Mode of action and development of resistance to quinolones.
Cullmann W
Antibiot Chemother (1971); 1989; 42():287-300. PubMed ID: 2512843
[No Abstract] [Full Text] [Related]
16. Bacterial resistance to quinolones: mechanisms and clinical importance.
Wolfson JS; Hooper DC
Rev Infect Dis; 1989; 11 Suppl 5():S960-8. PubMed ID: 2549610
[TBL] [Abstract][Full Text] [Related]
17. The quinolones.
Neu HC
Infect Dis Clin North Am; 1989 Sep; 3(3):625-39. PubMed ID: 2671143
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci.
Linde HJ; Schmidt M; Fuchs E; Reischl U; Niller HH; Lehn N
Antimicrob Agents Chemother; 2001 May; 45(5):1553-7. PubMed ID: 11302827
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of quinolone resistance in Salmonella.
Cloeckaert A; Chaslus-Dancla E
Vet Res; 2001; 32(3-4):291-300. PubMed ID: 11432420
[TBL] [Abstract][Full Text] [Related]
20. [In vitro evaluation of lomefloxacin].
Dette GA; Knothe H
Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
